Brief: Vaxil Provides Strategy Update From Conclusion Of Covid-19 Challenge Study

Vaxil Bio

17/02/2021 20:50

Feb 17 (Reuters) - Vaxil Bio Ltd  VXL.V :
    * VAXIL PROVIDES STRATEGY UPDATE FROM CONCLUSION OF COVID-19
CHALLENGE STUDY
    * VAXIL BIO - USAMRIID COVID-19 MOUSE MODEL CHALLENGE
EXPERIMENT
DEMONSTRATED THAT CO'S SP-BASED VACCINE CANDIDATE GENERATED
SPECIFIC IMMUNE RESPONSE
    * VAXIL BIO - WILL EVALUATE ALTERNATE PEPTIDE DELIVERY
APPROACHES,
INCLUDING ORAL ADMINISTRATION
    * VAXIL BIO LTD - IMMUNE RESPONSE GENERATED BY VACCINE
CANDIDATE
WAS NOT ACCOMPANIED BY VACCINE PROTECTION OF ANIMALS

Source text for Eikon:  ID:nGNX1lVXs5 
Further company coverage:  VXL.V 

 ((Reuters.Briefs@thomsonreuters.com;))